This presentation is now available to view on-demand
Human pluripotent stem cells (hPSCs) carrying disease-associated genetic defects hold great potential for interrogating the molecular basis of human disease. In recent years, the rapid development of engineered nucleases and their use to introduce or correct such disease-causing mutations in hPSCs has significantly broadened the spectrum of diseases that can be modeled. An overview of TALEN and CRISPR based technology and their application in models of genetic disease will be the focus of a forthcoming webinar presented by Cell Press on “Genome editing of stem cells” on June 27th. We hope that you will join us for the chance to hear from Chad Cowan, Joseph Wu and Feng Zhang on the latest findings in this rapidly moving area of the stem cell field.
Who should attend:
Anyone interested in genetic engineering of stem cells to study the molecular basis of disease, or to generate screening platforms for potential therapeutics
Dr. Chad Cowan Harvard Stem Cell Inst. Director View Bio
Dr. Joseph Wu Director Stanford Cardiovascular Institute View Bio